News & Events
FEATURED STORY
Featured, Press Release
Phagenesis Appoints Stephen Oesterle, MD, to Board of Directors
In the News
May 11, 2026
Atlantic Health introduces Phagenyx®: Advanced therapy for post-stroke swallowing disorders
March 4, 2024
Phagenesis Successfully Closes a $42M Series D Financing Round Led by EQT Life Sciences and Sectoral Asset Management
Webinars
Stories
Events
We’re hitting the road to share the latest clinical evidence, patient outcomes, and real-world impact of Phagenyx at leading stroke, neurology, and rehabilitation conferences across the globe. Meet the Phagenesis team, see a live demo, or attend our speaking sessions.
As Seen In
Press Releases
May 11, 2026
Atlantic Health introduces Phagenyx®: Advanced therapy for post-stroke swallowing disorders
September 1, 2024
Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following Recent Close of $42M Series D Financing
March 4, 2024
